Advisors Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $402K | Buy |
3,534
+693
| +24% | +$78.8K | 0.01% | 986 |
|
|
2025
Q1 | $299K | Buy |
2,841
+589
| +26% | +$61.9K | 0.01% | 1047 |
|
|
2024
Q4 | $241K | Buy |
+2,252
| New | +$241K | ﹤0.01% | 1092 |
|
|
2023
Q4 | – | Sell |
-6,919
| Closed | -$415K | – | 1422 |
|
|
2023
Q3 | $415K | Sell |
6,919
-132
| -2% | -$7.91K | 0.01% | 946 |
|
|
2023
Q2 | $508K | Sell |
7,051
-49
| -0.7% | -$3.53K | 0.01% | 926 |
|
|
2023
Q1 | $522K | Sell |
7,100
-114
| -2% | -$8.39K | 0.01% | 924 |
|
|
2022
Q4 | $482K | Sell |
7,214
-4,853
| -40% | -$324K | 0.01% | 936 |
|
|
2022
Q3 | $648K | Sell |
12,067
-611
| -5% | -$32.8K | 0.01% | 866 |
|
|
2022
Q2 | $706K | Sell |
12,678
-8,283
| -40% | -$461K | 0.01% | 857 |
|
|
2022
Q1 | $1.47M | Buy |
20,961
+6,478
| +45% | +$455K | 0.02% | 687 |
|
|
2021
Q4 | $1.4M | Buy |
14,483
+3,150
| +28% | +$304K | 0.02% | 734 |
|
|
2021
Q3 | $985K | Sell |
11,333
-157
| -1% | -$13.6K | 0.02% | 827 |
|
|
2021
Q2 | $940K | Sell |
11,490
-47
| -0.4% | -$3.85K | 0.01% | 858 |
|
|
2021
Q1 | $1.1M | Sell |
11,537
-232
| -2% | -$22.1K | 0.02% | 792 |
|
|
2020
Q4 | $730K | Buy |
11,769
+2,371
| +25% | +$147K | 0.01% | 865 |
|
|
2020
Q3 | $559K | Buy |
9,398
+3,167
| +51% | +$188K | 0.01% | 889 |
|
|
2020
Q2 | $435K | Buy |
6,231
+699
| +13% | +$48.8K | 0.01% | 937 |
|
|
2020
Q1 | $251K | Sell |
5,532
-3,201
| -37% | -$145K | 0.01% | 1059 |
|
|
2019
Q4 | $568K | Sell |
8,733
-1,380
| -14% | -$89.8K | 0.01% | 947 |
|
|
2019
Q3 | $628K | Sell |
10,113
-4,417
| -30% | -$274K | 0.01% | 908 |
|
|
2019
Q2 | $1.04M | Sell |
14,530
-498
| -3% | -$35.5K | 0.02% | 770 |
|
|
2019
Q1 | $1.18M | Sell |
15,028
-284
| -2% | -$22.3K | 0.02% | 758 |
|
|
2018
Q4 | $1.3M | Buy |
15,312
+1,518
| +11% | +$128K | 0.03% | 673 |
|
|
2018
Q3 | $2.36M | Buy |
13,794
+3,532
| +34% | +$605K | 0.04% | 543 |
|
|
2018
Q2 | $1.33M | Buy |
10,262
+4,365
| +74% | +$564K | 0.02% | 742 |
|
|
2018
Q1 | $559K | Buy |
5,897
+426
| +8% | +$40.4K | 0.01% | 1030 |
|
|
2017
Q4 | $467K | Buy |
5,471
+1,617
| +42% | +$138K | 0.01% | 1092 |
|
|
2017
Q3 | $327K | Buy |
+3,854
| New | +$327K | 0.01% | 1158 |
|